Cbt Pharmaceuticals is an innovative biotechnology company based in Pleasanton, CA, specializing in the discovery and development of oncology therapies. Their mission is to combat pan-cancer with precision by harnessing the immune system and targeting specific molecular pathways to inhibit cancer. With a strong focus on sound mechanistic and scientific rationale, Cbt Pharmaceuticals aims to save the lives of patients who have exhausted treatment options and improve clinical benefits.
Driven by their vision to become a global leader in the development of novel medicines for cancer patients, Cbt Pharmaceuticals is dedicated to pushing the boundaries of innovation. Their pipeline includes promising candidates such as Vebreltinib, APL-101, Uproleselan, APL-106, APL-102, and APL-501, which have the potential to revolutionize cancer treatment. With a commitment to scientific excellence and a patient-centric approach, Cbt Pharmaceuticals is at the forefront of advancing oncology therapies.
Generated from the website